Managed Care News and Research

RSS

Amgen and Merck expand collaboration for Talimogene laherparepvec-KEYTRUDA combination study

Amgen and Merck, known as MSD outside the U.S. and Canada, today announced an expanded collaboration to evaluate the efficacy and safety of talimogene laherparepvec, Amgen's investigational oncolytic immunotherapy, in combination with KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in a Phase 1, open-label trial of patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN).

1 Jun 2015

Amgen announces AMG 416 Phase 3 results for treatment of secondary hyperparathyroidism in CKD patients

Amgen today announced pooled data from two pivotal Phase 3, global, randomized, placebo-controlled trials evaluating AMG 416, a novel calcimimetic, for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease (CKD) receiving hemodialysis.

29 May 2015

Amgen creates catalog of qualified tools and reagents to advance basic discoveries in biology

Amgen today announced the creation of a catalog of qualified tools and reagents available to academic institutions to help further research and advance basic discoveries in biology, as well as deepen relationships with academic institutions.

29 May 2015

Metformin can reduce risk of open-angle glaucoma in people with diabetes

Taking the medication metformin hydrochloride was associated with reduced risk of developing the sight-threatening disease open-angle glaucoma in people with diabetes, according to a study published online by JAMA Ophthalmology.

29 May 2015

Amgen to present clinical data on multiple blood cancer treatments at EHA 2015

Amgen today announced that it will present data from multiple Kyprolis (carfilzomib) for Injection, BLINCYTO (blinatumomab), oprozomib and Nplate (romiplostim)‎ studies at the 20th Congress of the European Hematology Association taking place in Vienna, June 11 - 14, 2015.

28 May 2015

MedVantx launches MedStart Formulary Connect program for health systems and ACOs

MedVantx, Inc., a leading provider of point-of-care medication access, adherence and direct-to-patient consumer engagement programs, today announced the Company's MedStart Formulary Connect program. This innovative program equips leading health systems and ACOs with new formulary management tools that are designed to build greater alignment and advance the traditional medication formulary program upstream in the value chain to the point of care.

19 May 2015

ORIG3N, LabCorp form strategic partnership

ORIG3N, Inc., a pioneer in regenerative medicine and provider of induced pluripotent stem cell (iPSC) storage, called LifeCapsule, today announced a strategic collaboration with Laboratory Corporation of America Holdings.

19 May 2015

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

UCB, a global biopharmaceutical company focusing on immunology and neurology treatment and research, is sponsoring several data presentations on Cimzia (certolizumab pegol) at Digestive Disease Week 2015, taking place in Washington, DC from May 16-19.

17 May 2015

Buckeye Health Plan receives Dorland Health Case in Point Award

Buckeye Health Plan announced today that it's been awarded a Dorland Health Case in Point Award for its Pregnancy Specialty Care Management Program. The Case in Point Platinum Awards recognizes successful case management programs that focus on the continuum of care coordination.

17 May 2015

UBM Medica recognized with three national accolades by ASHPE

UBM Medica announced today that Physicians Practice, a leading online community for physicians and practice management professionals, has been recognized by the American Society of Healthcare Publication Editors with three national accolades.

13 May 2015

Managing cancer at work: Johns Hopkins launches new service for all employees

Johns Hopkins Medicine has created and launched Managing Cancer at Work, a new and novel health benefit program offered free of charge for its more than 42,000 combined full-time equivalent employees.

12 May 2015

Meritage ACO named winner of Dorland Health Case In Point Platinum Award

Zynx Health™, the market leader in providing evidence- and experience-based clinical improvement and mobile care coordination solutions, proudly congratulates Meritage Accountable Care Organization for being named a winner in the 6th Annual Dorland Health Case In Point Platinum Awards Program.

12 May 2015

AMC Health to collaborate with URAC on national telehealth standards development initiative

AMC Health, a leading provider of 'real-time' patient management solutions has announced that it will collaborate with URAC on its national telehealth standards development initiative.

5 May 2015

Indivior reports top-line results from RBP-7000 phase 3 trial for treatment of schizophrenia

Indivior PLC today announced top-line results from its phase 3 clinical trial of RBP-7000, an investigational drug in development for the treatment of schizophrenia. In this pivotal study, both doses of RBP-7000 tested, 90 mg and 120 mg administered once-monthly, met the primary endpoint with statistically and clinically significant reductions in the symptoms of acute schizophrenia over an 8-week treatment period.

5 May 2015

ICD-10 Clinical Modification: an interview with Dr. Jon Elion, Founder, ChartWise Medical Systems

ICD-10 is the tenth revision to the World Health Organization’s (WHO) International Classification of Diseases. ICD-10, like its predecessor, ICD-9, is based on a set of unique alphanumeric codes to identify known diseases and other health problems...

29 Apr 2015

ACA incentives driving healthcare transition improvements in hospitals

Regardless of one's views on the Affordable Care Act, it has succeeded in placing long-overdue attention on improving management of patient transitions from one care setting to another, according to a leading health care policy analyst speaking today at the National Quality Summit, sponsored by the National Association for Healthcare Quality.

27 Apr 2015

BMC pathologists develop protocols for processing, preserving forensic evidence

Boston Medical Center pathologists have developed a set of protocols for processing and preserving forensic evidence, such as shrapnel, bullets and other projectiles, in surgical specimens (i.e. amputated limbs, injured organs, etc.) after a terrorist attack based on lessons learned from the Boston Marathon bombing.

22 Apr 2015

Catamaran acquires Healthcare Solutions for $405 million

Catamaran Corporation, a leading provider of pharmacy benefit management (PBM) services and technology solutions, announced today the completion, effective as of April 8, 2015, of its previously disclosed acquisition of Healthcare Solutions, for a purchase price of $405 million in cash, subject to certain customary post-closing adjustments. The purchase price was funded from Catamaran's existing cash balance.

9 Apr 2015

Amgen's Vectibix (panitumumab) receives EC approval for treatment patients with WT RAS mCRC

Amgen today announced that the European Commission approved a new use of Vectibix (panitumumab) as first-line treatment in combination with FOLFIRI for the treatment of adult patients with wild-type (WT) RAS metastatic colorectal cancer (mCRC).

6 Apr 2015

Study investigates health outcomes of Medicare beneficiaries enrolled in MA plans at member-level

Inovalon, a leading technology company providing advanced cloud-based analytics and data-driven intervention platforms to the healthcare industry and the Special Needs Plan (SNP) Alliance, released today the largest analysis ever performed on dual eligible quality outcomes, entitled "An Investigation of Medicare Advantage Dual Eligible Member-Level Performance on the Centers for Medicare and Medicaid Services (CMS) Five-Star Quality Measures."

31 Mar 2015

Managed Care News and Research

Amgen and Merck expand collaboration for Talimogene laherparepvec-KEYTRUDA combination study

Amgen announces AMG 416 Phase 3 results for treatment of secondary hyperparathyroidism in CKD patients

Amgen creates catalog of qualified tools and reagents to advance basic discoveries in biology

Metformin can reduce risk of open-angle glaucoma in people with diabetes

Amgen to present clinical data on multiple blood cancer treatments at EHA 2015

MedVantx launches MedStart Formulary Connect program for health systems and ACOs

ORIG3N, LabCorp form strategic partnership

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

Buckeye Health Plan receives Dorland Health Case in Point Award

UBM Medica recognized with three national accolades by ASHPE

Managing cancer at work: Johns Hopkins launches new service for all employees

Meritage ACO named winner of Dorland Health Case In Point Platinum Award

AMC Health to collaborate with URAC on national telehealth standards development initiative

Indivior reports top-line results from RBP-7000 phase 3 trial for treatment of schizophrenia

ICD-10 Clinical Modification: an interview with Dr. Jon Elion, Founder, ChartWise Medical Systems

ACA incentives driving healthcare transition improvements in hospitals

BMC pathologists develop protocols for processing, preserving forensic evidence

Catamaran acquires Healthcare Solutions for $405 million

Amgen's Vectibix (panitumumab) receives EC approval for treatment patients with WT RAS mCRC

Study investigates health outcomes of Medicare beneficiaries enrolled in MA plans at member-level

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News